About Bailian
Founded in 2021 and located in the Wisdom Square of Pujiang Lingang International Science and Technology City, BIOSMELT Pharma is a leading CDO/CMO one-stop service company focusing on ATMP drugs (cell and gene therapy) in China. At present, the main business of CDO business includes CDO business - new delivery vector development (DD), novel cell technology development (CD), production process development (PD), analytical method development (AD), formulation development (FD), quality system development (QD), and CMO business - small test (LBM), pilot test (PBM), commercial production (CM). At the same time, it also carries out registration and application in China, the United States and Europe, clinical research consulting, business development and other businesses, and comprehensively accelerates the proof of concept of bioinnovative drugs for scientific research institutions and start-ups.
One-stop CDO/CMO service provider
Bailianprovides CRO/CDO/CMO services covering all stages of the whole cycle of new drug development for biotech entrepreneurs and enterprises, and can also provide one-stop outsourcing services covering different stages according to the requirements of different customers.
One-stop turnkey solution
Click on the module to learn more
CRO Key Technologies
Bailianfocuses on ATMP drugs, and its core technologies include novel delivery technology and novel cell technology. Among them, the delivery technology mainly includes exosome delivery technology and VLP delivery technology; Cell technology includes general-purpose immune cell technology and iPSC technology.
CDO Service
Bailianprovides comprehensive services from drug development to production for biotech companies, helping drugs from concept to clinical trials in all development steps. Helping pharmaceutical companies shorten drug development cycles, reduce R&D costs, and leverage expertise to accelerate drug time-to-market
CMO Service
According to the different stages of innovative drug development, the demand for outsourcing production services is also different, and Bailian Pharma provides complete services with professional facilities, personnel and management to meet the needs of customers at different stages.
Pilot production
(non-GMP)
It is used for preclinical in vivo and in vitro validation, toxicology and pharmacology research
Pilot production
(GMP-like)
Stable three-batch production for IIT and IND filings
Pilot production
(cGMP)
For IND or registration clinical phase I-II production
One-stop solution
Bailian Pharma starts from the lead molecule of innovative drugs, to early proof-of-concept, preclinical research, IND filing, to registrational clinical trial phase I-III, until the drug NDA is approved for marketing and commercialization...... In addition to providing professional and high-quality CRO, CDO, CMO and other services in all aspects of the drug development process, it also provides one-stop overall solutions to help customers develop innovative drugs throughout the process, seamlessly connect all links, and achieve customer requirements in the most efficient, fast and economical manner.
Innovation Center
As an innovation center established and operated independently, BaiLian Pharmaceutical Innovation Center encourages innovative cooperation models, focuses on cutting-edge medical fields such as gene and cell therapy, relies on BaiLian's strong scientific research strength and commercialization capabilities, and co-incubates and supports the growth of high-quality local innovative enterprises with MNC, and promotes the early R&D and clinical transformation of drugs.
